do i need to wean off semaglutide How Stop Safely: Weaning Guide Coming Off Wegovy and Ozempic:

Metabolism & Elimination Both peptides undergo similar metabolic pathways despite their structural differences: GLP1 metabolism: Proteolytic cleavage of the peptide backbone across multiple tissues Sequential beta-oxidation of the fatty acid side chain No organ-specific metabolism with degradation occurring in multiple tissues simultaneously Six identified metabolites in human plasma, with metabolite P3 comprising approximately 7.7% of circulating drug-related material Intact peptide predominance with 69-83% of circulating material remaining as intact GLP1 Cagrilintide metabolism: Similar proteolytic pathways to GLP1 due to peptide structure Fatty acid chain processing through beta-oxidation mechanisms Albumin-mediated protection reducing enzymatic access to the peptide backbone Reversible albumin binding allowing gradual release and metabolism No specific organ predominance for metabolic clearance The remarkably similar half-lives of both peptides (159-195 hours for cagrilintide, 145-165 hours for GLP1) enable synchronized pharmacokinetic profiles ideal for fixed-dose combination therapy

Could mixing these peptides lead to a synergistic effect

GST isoforms (GSTM1, GSTP1, GSTT1) are expressed in the cytosol, mitochondria, and nucleus across multiple organs, including the liver, kidneys, lungs, brain, and placenta, exhibiting broad substrate specificity against electrophiles (molecules deficient in electron pairs) and ROS (2733)

Chicken and turkey: Lean options that deliver a lot of protein in smaller servings